Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

2 thoradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry
    vacsaín chaolaithe bheo Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Comhthéacs 'I gcás vacsaíní caolaithe beo, ní mór cruthúnas ar chobhsaíocht shaintréithe chaolú an tsíl a thabhairt.' Tagairt "Rialachán (AE) 2019/6 maidir le táirgí íocshláinte tréidliachta agus lena n-aisghairtear Treoir 2001/82/CE, CELEX:32019R0006/GA"
    Lebendimpfstoff | abgeschwächter Impfstoff | abgeschwächter Lebendimpfstoff | Lebendvakzine
    de
    Sainmhíniú Lebendimpfstoff aus Mikroorganismen oder Viren, die infolge Kultur-oder anderweitiger Bedingungen-ihre Virulenz zwar verloren, aber die Fähigkeit, eine schützende Immunantwort zu stimulieren, behalten haben. Tagairt W'buch Immunologie
    attenuated live vaccine | live attenuated vaccine | live vaccine | LAV
    en
    Sainmhíniú vaccine that contains a weakened form of the organism that causes the disease Tagairt "COM-EN, based on: - World Health Organization, Bulletin of the WHO, 'WHO supports fair access to influenza A (H1N1) vaccine.' http://www.who.int/bulletin/volumes/87/9/09-030909/en/ [28.08.2014]"
    Nóta "The organism can be a bacterium or a virus. One concern that must be considered is the potential for the vaccine virus to revert to a form capable of causing disease. Mutations that can occur when the vaccine virus replicates in the body may result in more a virulent strain. This is very unlikely, as the vaccine virus’s ability to replicate at all is limited; however, it is taken into consideration when developing an attenuated vaccine. Reference: Different Types of Vaccines. History of Vaccines. The College of Physicians of Philadelphia, http://www.historyofvaccines.org/content/articles/different-types-vaccines [20.1.2014] See also: - live attenuated virus vaccine (narrower) [ IATE:1141473 ] - inactivated vaccine (related) [ IATE:1073854 ]"
    vaccin vivant atténué | vaccin vivant | vaccin atténué
    fr
  2. AGRICULTURE, FORESTRY AND FISHERIES|agricultural activity|animal health
    vacsaín bheo Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Comhthéacs 'I gcásanna vacsaíní beo i gcomhair zúnóisí de réir bhrí Threoir 2003/99/CE ó Pharlaimint na hEorpa agus ón gComhairle atá le húsáid i gcomhair bia-ainmhithe, is gá na staidéir sin a chur san áireamh, go háirithe cé chomh fada a mhaireann an t-orgánach ag an mball insteallta.' Tagairt "Rialachán (AE) 2019/6 maidir le táirgí íocshláinte tréidliachta agus lena n-aisghairtear Treoir 2001/82/CE, CELEX:32019R0006/GA"
    Impfstamm-Lebendvakzine
    de
    live vaccine | live-strain vaccine
    en
    Sainmhíniú any vaccine that does not contain an inactivated (killed) product, although it is recognised that in the case of viruses they cannot be considered truly alive Tagairt "COM-Terminology Coordination, based on: World Organisation for Animal Health (OIE). 'Chapter 1.1.8. Principles of Veterinary Vaccine Production' (20.5.2019). Terrestrial Manual 2018."
    Nóta Vaccines may be prepared as live or inactivated (killed) products. Some live vaccines are prepared from low virulence, mild, field isolates of a disease-causing agent that have been found to be safe and effective when administered by an unnatural route or under other conditions where exposure to the microorganism will immunise rather than cause disease. Other live vaccines are prepared from isolates of disease-causing agents that have been modified by passage through laboratory animals, culture media, cell cultures, or avian embryos to select a variant of reduced virulence. The development of recombinant DNA (rDNA) procedures has provided some unique opportunities for vaccine production. Modified live vaccines may now be specifically produced by deletion of virulence-related genes from a microorganism. Others are produced by the insertion of genes that code for specific immunising antigens from a disease-causing microorganism into a nonvirulent vector microorganism. Nucleic-acid-mediated vaccines containing plasmid DNA have been developed. The DNA is usually in plasmid form and codes for immunising antigens from disease-causing microorganisms. Killed products may contain: 1) Cultures of microorganisms that have been inactivated by chemical or physical means; 2) Inactivated toxins; or 3) Subunits (antigenic parts of microorganisms) that have been extracted from cultures or that have been produced through rDNA procedures.
    vaccin vivant buck
    fr